These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9214464)

  • 1. Nitric oxide formation lowers norepinephrine-induced intrahepatic resistance without major effects on the metabolism in the perfused rat liver.
    Weidenbach H; Nussler AK; Shu Z; Adler G; Beckh K
    Hepatology; 1997 Jul; 26(1):147-54. PubMed ID: 9214464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nitric oxide in hemodynamic and metabolic alterations induced by prostaglandin F2 alpha in the perfused rat liver.
    Weidenbach H; Beckh K; Günthör M; Lerch MM; Adler G
    Biochim Biophys Acta; 1995 Oct; 1245(2):181-6. PubMed ID: 7492575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG; Thiemermann C
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
    Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
    J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
    Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
    Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin impairs biliary glutathione and HCO3- excretion and blocks the choleretic effect of nitric oxide in rat liver.
    Trauner M; Nathanson MH; Rydberg SA; Koeppel TA; Gartung C; Sessa WC; Boyer JL
    Hepatology; 1997 May; 25(5):1184-91. PubMed ID: 9141437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hypoxia on nitric oxide formation and leukotriene metabolism in the perfused rat liver].
    Wettstein M; Häussinger D
    Zentralbl Chir; 1994; 119(5):328-33. PubMed ID: 7517604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
    Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
    Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo.
    Fukumura D; Yonei Y; Kurose I; Saito H; Ohishi T; Higuchi H; Miura S; Kato S; Kimura H; Ebinuma H; Ishi H
    Hepatology; 1996 Jul; 24(1):141-9. PubMed ID: 8707254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOS3 is involved in the increased protein and arginine metabolic response in muscle during early endotoxemia in mice.
    Luiking YC; Hallemeesch MM; Lamers WH; Deutz NE
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1258-64. PubMed ID: 15644457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock.
    Pullamsetti SS; Maring D; Ghofrani HA; Mayer K; Weissmann N; Rosengarten B; Lehner M; Schudt C; Boer R; Grimminger F; Seeger W; Schermuly RT
    Thromb Haemost; 2006 Apr; 95(4):720-7. PubMed ID: 16601845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
    Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
    Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage inflammatory protein-1 alpha production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine.
    Mühl H; Dinarello CA
    J Immunol; 1997 Nov; 159(10):5063-9. PubMed ID: 9366434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide synthase inhibitor increases hepatic injury with formation of oxidative DNA damage and microcirculatory disturbance in endotoxemic rats.
    Takemura S; Minamiyama Y; Inoue M; Kubo S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 2000; 47(35):1364-70. PubMed ID: 11100353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of insulin on the metabolism of glucose in uteri isolated from ovariectomized and non ovariectomized underfed rats.
    Casalino-Matsuda SM; Linares JA; Campos LM; Goldraij A
    Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):337-41. PubMed ID: 11133170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
    Moore MC; Dicostanzo CA; Smith MS; Farmer B; Rodewald TD; Neal DW; Williams PE; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E768-77. PubMed ID: 18212022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.